Terms of Service
Effective Date: April 1, 2026

Acceptance of Terms
By accessing or using Rxentra, you agree to comply with these terms and all applicable laws and regulations. If you do not agree with any part of these terms, you must discontinue use of the platform immediately.

Eligibility
Services are available only to licensed businesses and authorized healthcare providers who meet regulatory requirements. You must be authorized to operate in your jurisdiction and provide valid documentation upon request.

Account Responsibilities
Users are responsible for maintaining the confidentiality of their account credentials and all activities under their account. Promptly notify us of any unauthorized use of your account.

Compliance Obligations

Orders & Payments
All orders are subject to availability, pricing, and compliance verification.
- Payment terms are due as specified at checkout or in your account agreement
- Pricing is subject to change with reasonable notice
- Order acceptance is contingent on compliance verification and product availability

Compliance Obligations
Customers must maintain valid licenses and comply with all applicable pharmaceutical regulations including DSCSA, FDA, and DEA requirements. Failure to maintain compliance may result in account suspension.

Returns & Refunds
Returns are governed by compliance policies and product eligibility. Not all products are eligible for return due to regulatory requirements. Contact our support team to initiate a return request and obtain authorization.

Limitation of Liability
Rxentra is not liable for indirect, incidental, or consequential damages arising from the use of its services. Our total liability shall not exceed the amount paid by you in the three months preceding the claim.

Account Termination
We may update these terms at any time. Continued use of the platform constitutes acceptance of
changes. We will provide reasonable notice of material changes via email or platform notification.

Changes to Terms
We may update these terms at any time. Continued use of the platform constitutes acceptance of changes. We will provide reasonable notice of material changes via email or platform notification.
